Kazuhiro Tanaka

An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway

Deliang Guo, Felicia Reinitz, Mary Youssef et al. · Cancer Discovery · 2011 · 435 citations · Full text

Chemoprevention Strategy, Cell Death, Gbm Cell Lines +16

mTOR Complex 2 Controls Glycolytic Metabolism in Glioblastoma through FoxO Acetylation and Upregulation of c-Myc

Kenta Masui, Kazuhiro Tanaka, David Akhavan et al. · Cell Metabolism · 2013 · 390 citations · Full text

Neuro-oncology, Medicine, Mtor Complex 2 +9

Oncogenic EGFR Signaling Activates an mTORC2–NF-κB Pathway That Promotes Chemotherapy Resistance

Kazuhiro Tanaka, Ivan Babić, David A. Nathanson et al. · Cancer Discovery · 2011 · 278 citations · Full text

Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment

Kazuhiro Tanaka, Takashi Sasayama, Yasuhiro Irino et al. · Journal of Clinical Investigation · 2015 · 227 citations · Full text

Recurrent mutations of <scp><i>CD79B</i></scp> and <scp><i>MYD88</i></scp> are the hallmark of primary central nervous system lymphomas

Taishi Nakamura, Kensuke Tateishi, T. Niwa et al. · Neuropathology and Applied Neurobiology · 2015 · 220 citations